Northern Trust’s Arcadia Biosciences RKDA Stock Holding History
Bought
Maintained
Sold
Other funds holding RKDA
AC
SM
Northern Trust's RKDA Position: Q1 2023 in Review
Northern Trust sold out of Arcadia Biosciences (RKDA) in Q1 2023, closing a stake of 723 shares — an estimated $7.84K sold.
Northern Trust first reported a position in RKDA in Q3 2015 and held it in 20 quarters. The position peaked at $213K in Q3 2015. 15 funds tracked by Wall St. Rank hold RKDA as of Q1 2023.
- Northern Trust reported no remaining Arcadia Biosciences position as of Q1 2023 after selling out during the quarter.
- Northern Trust sold 723 Arcadia Biosciences shares in Q1 2023, an estimated $7.84K.
- Northern Trust first reported a position in Arcadia Biosciences in Q3 2015 and held it in 20 quarters.
- Northern Trust's Arcadia Biosciences position peaked at $213K in Q3 2015.
- 15 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2023.
Based on Northern Trust's 13F filing for Q1 2023, filed 15 May 2023.